Serum IL-1RA concentration was negatively correlated with the end-stage liver disease score model, IL-1RA concentration, and IL-1RA/IL-1β ratio of HBV-ACLF patients in the death group was pronouncedly lower than those in the survival group [17]. Here, IL6R is linked to liver disorder.